Jul 22, 2026 07:05AM
Jul 22, 2026 07:05AM
Mar 2, 2026 06:10AM
Mar 2, 2026 06:01AM
Mar 2, 2026 06:01AM
Feb 11, 2026 07:00AM
Dec 12, 2025 10:47AM Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance
Dec 4, 2025 07:10AM
Dec 4, 2025 07:02AM
Dec 4, 2025 07:00AM
Nov 5, 2025 07:00AM
Nov 4, 2025 07:15AM
Nov 4, 2025 07:15AM
Sep 11, 2025 07:00AM Royalty Pharma Investor Day Highlights Strong Growth Outlook and Company’s Plans to Drive Value Creation
Sep 2, 2025 07:15AM
Sep 2, 2025 07:15AM
Sep 2, 2025 07:05AM
Aug 25, 2025 06:10AM
Aug 25, 2025 06:10AM
Aug 25, 2025 06:10AM
Aug 25, 2025 06:01AM BeOne Medicines sells IMDELLTRA royalty rights for up to $950 million
Aug 25, 2025 06:00AM
Aug 6, 2025 07:00AM
Jul 17, 2025 08:15AM
Jul 17, 2025 08:15AM
May 16, 2025 04:30PM
May 16, 2025 06:12AM
May 12, 2025 04:17PM Royalty Pharma plc (RPRX) Announces Shareholder Approval of its External Manager Acquisition
May 12, 2025 04:15PM
May 12, 2025 04:15PM
May 12, 2025 04:15PM
May 8, 2025 07:15AM
Feb 11, 2025 07:15AM
Jan 29, 2025 09:04AM
Jan 29, 2025 09:00AM Royalty Pharma Announces Sale of MorphoSys Development Funding Bonds
Jan 10, 2025 07:30AM
Jan 10, 2025 07:16AM
Jan 10, 2025 07:15AM
Nov 7, 2024 07:11AM
Nov 7, 2024 07:10AM
Nov 6, 2024 07:15AM
Oct 7, 2024 09:28AM TD Cowen Reiterates Buy Rating on Royalty Pharma (RPRX)
Aug 8, 2024 07:00AM
May 28, 2024 07:10AM
May 28, 2024 07:10AM
May 9, 2024 07:00AM
May 9, 2024 06:45AM
May 9, 2024 06:45AM
Feb 15, 2024 07:30AM Royalty Pharma Reports Q4 and Full Year 2023 Results
Jan 8, 2024 07:00AM

1,171,469 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All